Related references
Note: Only part of the references are listed.Efficacy and safety of home-based subcutaneous immunoglobulin replacement therapy in paediatric patients with primary immunodeficiencies
M. Borte et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies
Nima Rezaei et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Threshold Model for Extremity Compartment Syndrome in Swine
John Kalns et al.
JOURNAL OF SURGICAL RESEARCH (2011)
Regulatory acceptability of the minipig in the development of pharmaceuticals, chemicals and other products
Jan Willem van der Laan et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2010)
Subcutaneous immunoglobulin: opportunities and outlook
S. Misbah et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Quantitative structure-property relationship modeling of skin sensitization: A quantitative prediction
Sharath Golla et al.
TOXICOLOGY IN VITRO (2009)
Rapid subcutaneous immunoglobulin administration every second week results in high and stable serum immunoglobulin G levels in patients with primary antibody deficiencies
R. Gustafson et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Subcutaneous Administration of IgG
Melvin Berger
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2008)
Cutaneous tactile allodynia associated with microvascular dysfunction in muscle
Andre Laferriere et al.
MOLECULAR PAIN (2008)
Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration
Gregory I. Frost
EXPERT OPINION ON DRUG DELIVERY (2007)
Immunoglobulin treatment for primary antibody deficiencies - Advantages of the subcutaneous route
Ann Gardulf
BIODRUGS (2007)
Replacement IgG therapy and self-therapy at home improve the health-related quality of life in patients with primary antibody deficiencies
Ann Gardulf et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2006)
A recombinant human enzyme for enhanced interstitial transport of therapeutics
L. H. Bookbinder et al.
JOURNAL OF CONTROLLED RELEASE (2006)
The minipig in toxicology
Ove Svendsen
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2006)
The minipig in dermatotoxicology:: Methods and challenges
Joerg Andreas Mahl et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2006)
Patients' attitude to subcutaneous immunoglobulin substitution as home therapy
J. M. Kittner et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2006)
Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases
Hans D. Ochs et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2006)
Health-related quality of life and treatment satisfaction in North American patients with primary immunedeficiency diseases receiving subcutaneous IgG self-infusions at home
U Nicolay et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2006)
Evaluation of limb compartments with increased interstitial pressure. An improved noninvasive method for determining quantitative hardness
BD Steinberg
JOURNAL OF BIOMECHANICS (2005)
Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home
A Gardulf et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Subcutaneous immunoglobulin replacement in primary immunodeficiencies
M Berger
CLINICAL IMMUNOLOGY (2004)
Endothelin A receptor blockade reduces hepatic ischemia/reperfusion injury after warm ischemia in a pig model
D Uhlmann et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2003)
Lymphatic transport of proteins after s.c. injection: implications of animal model selection
CJH Porter et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Share Paper
